 | Up a level |
Journal Article
Christgen, Matthias, Bartels, Stephan 
ORCID: 0000-0002-8903-2345, Radner, Martin, Raap, Mieke, Rieger, Luisa, Christgen, Henriette, Gluz, Oleg, Nitz, Ulrike, Harbeck, Nadia, Lehmann, Ulrich and Kreipe, Hans
(2019).
ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profiling.
Gene Chromosomes Cancer, 58 (3).
S. 175 - 186.
HOBOKEN:
WILEY.
ISSN 1098-2264
Christgen, Matthias, Gluz, Oleg, Harbeck, Nadia, Kates, Ronald E., Raap, Mieke, Christgen, Henriette, Clemens, Michael, Malter, Wolfram, Nuding, Benno, Aktas, Bahriye, Kuemmel, Sherko, Reimer, Toralf, Stefek, Andrea, Krabisch, Petra, Just, Marianne, Augustin, Doris, Graeser, Monika, Baehner, Frederick, Wuerstlein, Rachel, Nitz, Ulrike and Kreipe, Hans (2020). Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer. Cancer, 126 (22). S. 4847 - 4859. HOBOKEN: WILEY. ISSN 1097-0142
Grote, Isabel ORCID: 0000-0002-6731-187X, Bartels, Stephan ORCID: 0000-0002-8903-2345, Christgen, Henriette, Radner, Martin, Gronewold, Malte, Kandt, Leonie, Raap, Mieke ORCID: 0000-0001-8338-6209, Lehmann, Ulrich ORCID: 0000-0003-2350-6584, Gluz, Oleg, Graeser, Monika, Kuemmel, Sherko, Nitz, Ulrike, Harbeck, Nadia, Kreipe, Hans and Christgen, Matthias
(2022).
ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer.
Mod. Pathol., 35 (12).
S. 1804 - 1812.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1530-0285
Grote, Isabel ORCID: 0000-0002-6731-187X, Bartels, Stephan, Kandt, Leonie, Bollmann, Laura, Christgen, Henriette, Gronewold, Malte, Raap, Mieke, Lehmann, Ulrich, Gluz, Oleg, Nitz, Ulrike, Kuemmel, Sherko ORCID: 0000-0001-9355-494X, Zu Eulenburg, Christine, Braun, Michael, Aktas, Bahriye, Grischke, Eva-Maria, Schumacher, Claudia, Luedtke-Heckenkamp, Kerstin, Kates, Ronald, Wuerstlein, Rachel, Graeser, Monika, Harbeck, Nadia, Christgen, Matthias and Kreipe, Hans
(2021).
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer.
Cancer Med., 10 (23).
S. 8581 - 8595.
HOBOKEN:
WILEY.
ISSN 2045-7634